Can This 1 Thing Hurt Vaxart?
Vaxart (NASDAQ: VXRT) has been involved in the coronavirus vaccine race since the beginning. All of this means there is one big problem for Vaxart right now. Vaxart's biggest problem is the time it's taking the company to bring its candidate through development to commercialization.